IMproved PRegnancy Outcome by Early Detection

NCT01891240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2016-11-08

No results posted yet for this study

Summary

The overall objective of the IMPROvED project is to develop a sensitive, specific, high-throughput and economically viable early pregnancy screening test for preeclampsia.

This will involve a multicentre, phase IIa clinical predictive study to assess and refine novel and innovative prototype tests based on emerging metabolomic and proteomic technologies developed by SMEs (small to medium size enterprise) within the consortium. The study will i) recruit 5000 first-time pregnant women; ii) establish a high calibre biobank, augmented by accurate clinical metadata; iii) determine whether prototype predictive assays and algorithms translate to the clinical environment; iv) assess potential synergy of a combined metabolomic and proteomic approach and v) progress regulatory approval and development of the selected test into the clinical arena.

Conditions

  • Pre-eclampsia
  • Pregnancy
  • Pregnancy, High-risk
  • Pregnancy Complications

Sponsors & Collaborators

  • Keele University

    collaborator OTHER
  • University of Liverpool

    collaborator OTHER
  • Karolinska University

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Copenhagen Trial Unit, Center for Clinical Intervention Research

    collaborator OTHER
  • MedSciNet AB, Stockholm, Sweden

    collaborator UNKNOWN
  • MyCartis, Ghent, Belgium

    collaborator UNKNOWN
  • Metabolomic Diagnostics Ltd, Cork, Ireland

    collaborator UNKNOWN
  • Accelopment AG

    collaborator OTHER
  • University of Groningen, The Netherlands

    collaborator UNKNOWN
  • INFANT centre, University College Cork, Republic of Ireland

    collaborator UNKNOWN
  • Louise Kenny

    lead OTHER

Principal Investigators

  • Louise Kenny, Professor · INFANT Centre, University College Cork, Ireland

  • Philip N Baker, Professor · Keele Univeristy School of Medicine

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2017-10-31
Completion
2018-04-30

Countries

  • Ireland
  • Netherlands
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891240 on ClinicalTrials.gov